HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Decleor's Aromantic Inaugural Scent Evolved From Aromatherapy Foundation

This article was originally published in The Rose Sheet

Executive Summary

Decleor's Aromantic women's fragrance launch will build on the company's foundation as an aromatherapy-based skin care manufacturer.

You may also be interested in...



Eve.com

Company is "first online beauty products retailer to employ a TV ad campaign," eve.com claims. The TV effort, which broke Sept. 6 in major cities, follows print ads that premiered earlier this summer (1"The Rose Sheet" Aug. 9, p. 6). Like the print ads, TV spots feature "colorful, unusual creatures from nature." In the print campaign, the creatures are shown alongside makeup items that match their colors and textures, while in the TV spots, each creature "delivers color to transform a woman's lips, eyes or nails." Both campaigns were designed by Arnold Ingalls Moranville (San Francisco). Eve.com expects to spend about $20 mil. in online and offline advertising in its first year; the site has been up and running since June (2"The Rose Sheet" May 10, p. 6). Separately, eve.com will begin offering the Lorac makeup artist brand

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel